Navigation Links
Contract Research Organization WCCT Global Welcomes Lada Smirnova to the Executive Team as Chief Financial Officer
Date:9/4/2013

Costa Mesa, CA (PRWEB) September 04, 2013

WCCT Global, a contract research organization headquartered in Southern California, welcomes Lada Smirnova to the executive team as Chief Financial Officer. This addition is due to the organic growth WCCT Global has undergone in recent years and in preparation of acquiring more companies. Prior to joining WCCT, Lada held VP. of Finance and Accounting position with a well known CRO with experience in clinical trials across multiple therapeutic areas, from regulatory submissions and clinical affairs to medical monitoring and drug storage and distribution.

Prior to VP of Finance and accounting position, Lada held Director of Finance and Administration position with several high tech companies. In those roles Lada was responsible for short and long-range financial and business planning as well as directly responsible for day-to-day operations of finance, accounting, IT, human resources, customer service, warehouse, and facility management departments. Among other responsibilities Lada was a project leader on several software conversions involving redesigning the business process, successfully completed SOX compliance implementation, and had a leadership role in internally initiated successful company restructuring.

More about WCCT Global
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

To request more information on how WCCT Global has assist your next clinical study, CLICK HERE.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11080910.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Construction Audit and Cost Control Institute to Address "The Benefits of Auditing Construction Contracts and Contractors"
2. Study examines relationship of a commercial ACO contract with medical spending
3. Employment Lawyers at Gilman Law LLP Investigate Independent Contractor Misclassification in the State of Massachusetts Following the Recent Fedex Decision
4. Ben Davies, Chief Financial Officer at Octo Consulting Group was Announced Washington Business Journal (WBJ) 2013 Government Contracting CFO of the Year Award
5. Human Capital Resource, LLC, Adds Contract Staffing to Its Recruiting Services
6. BigToys Awarded Prestigious FAC79 Statewide Contract for Massachusetts
7. How Hiring a Painting Contractor in Michigan Can Save Homeowners Money
8. Specialty Drug Delivery Firm Integral BioSystems LLC to Participate in Contract Pharma Magazine’s 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
9. Michael Melville of IntelliSoft Group Joins Partner Firm, Contract Logix, as Group CEO
10. Fresh Healthy Vending Secures 90 New Contracts In June
11. Children from the poorest families are twice as likely to contract malaria than the least poor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: